MedTrace Logo

Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing Type 2 Diabetes

NCT07271433 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-02-23

No results posted yet for this study

Summary

Use of continuous glucose monitor (CGM) in post kidney transplant patients to better assess changes in glucose levels post kidney transplant

Conditions

  • Kidney Transplant

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • The Cleveland Clinic

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-29
Primary Completion
2024-11-12
Completion
2026-01-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07271433 on ClinicalTrials.gov